Article: Biotica Enters into a Research and License Agreement with Wyeth for Novel Rapamycin Analogs.

Article: Biotica Signs MTOR Inhibitor Deal With Wyeth For $195M.
BIOWORLD Today;  October 6, 2006 ;     700+ words ... ... Jennifer Boggs, Staff Writer Biotica Technology Ltd. partnered ... potential $195 million deal with Wyeth Pharmaceuticals to develop compounds against ... major drug collaboration for Biotica, which was established about ... deals," said Mark Bodmer, Biotica's CEO. Wyeth gains rights ...

Article: Biotica Signs GSK Deal Worth $127M for Each Marketed Drug.
BioWorld International;  January 14, 2009 ;     678 words ... ... s unpartnered programs. Biotica employs polyketide bioengineering ... means," said Ming Zhang, Biotica's senior vice president ... agreement," he added. Biotica previously partnered with ... potential $195 million deal with Wyeth Pharmaceuticals to develop compounds against ...

Article: Biotica Strikes Significant Collaboration Deal With ...
PR Newswire;  January 12, 2009 ;     700+ words ...GlaxoSmithKline & Biotica Technology Enter Collaboration to Discover ... England, January 12 /PRNewswire/ -- Biotica Technology Limited, a privately ... three year research collaboration, Biotica will use its bioengineering technology ...

Article: Biotica Raises $5 Million in Venture Financing.
PR Newswire;  January 6, 2003 ;     700+ words ... ... England, Jan. 6 /PRNewswire/ -- Biotica Technology Limited announced today the ... Florian Schonharting will join the Board of Biotica, representing BVF and Nordic Biotech respectively. Biotica's proprietary technology, spun out from ...

Article: Dr Alan Lewis Joins Biotica Board.
Cancer Weekly;  June 23, 2009 ;     700+ words ...Biotica Technology Ltd, the leader in discovery ... making and drug development experience to Biotica's board as the company continues to establish ... abstracts. Dr. Edward Hodgkin, CEO of Biotica, said, "We are delighted that Alan has ...

Article: United Kingdom : Biotica strikes significant collaboration ...
TendersInfo;  January 14, 2009 ;     700+ words ...Byline: pinto03 Biotica Technology Limited, a privately-held ... a three year research collaboration, Biotica will use its bioengineering technology ... Under the terms of the agreement, Biotica receives an initial cash payment, and ...

Article: Biotica grants Wyeth $195M rapamycin license.(Brief ...
Pharma Marketletter;  October 16, 2006 ;     642 words ...Biotica Technology, a privately-held UK biotechnology ... immunosuppressant with antiproliferative properties. Biotica has granted Wyeth worldwide rights to its ... for development and commercialization. Biotica will receive an initial payment, research ...